Beta
Back to UNH.US Analysis

Ticker

Value

empty

There is no following symbol in this watchlist.

  • Revenue by Segments
  • EPS
  • EPS Diluted
  • Revenue
  • Operation Income
  • Net Income
  • Operating Expenses
  • Cash Flow
  • Cash & Debt
  • Current Contract Liabilities
revenue-breakdown-chart

UNH Revenue by Segments

Revenue by Segments

Browsing restrictions can be lifted for a fee.

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

In Q3'25, UnitedHealth Group's (UNH) total revenue reached $113.1B USD, with Premiums contributing the largest share at $88.98B USD, followed by Products at $13.3B USD, Services at $9.75B USD, and Investment and other income at $1.13B USD. This marks a sequential increase from Q2'25's total of $108.6B USD, driven primarily by growth in Premiums and Services. Over the period from Q4'22 to Q3'25, UNH's revenue has shown steady overall growth, rising from $81.9B USD to $113.1B USD, with Premiums consistently dominating at 80-90% of the total and exhibiting a compound annual growth rate of approximately 10%. Products and Services have also expanded steadily, increasing 41% and 25% respectively, while Investment and other income remains volatile but minor, fluctuating between 0.1% and 2.7% of the total; notable inflection points include a Q4'23 spike in investment income to $2.18B USD, highlighting diversified yet premium-led revenue stability.